91 related articles for article (PubMed ID: 23778023)
21. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts.
Hirasawa Y; Kohno N; Yokoyama A; Inoue Y; Abe M; Hiwada K
Am J Respir Cell Mol Biol; 1997 Oct; 17(4):501-7. PubMed ID: 9376125
[TBL] [Abstract][Full Text] [Related]
22. Assessment of serum KL-6 as a prognostic marker in pulmonary tuberculosis patients.
Miwa S; Suzuki Y; Shirai M; Ohba H; Kanai M; Eifuku T; Suda T; Hayakawa H; Chida K
Int J Tuberc Lung Dis; 2013 Feb; 17(2):240-2. PubMed ID: 23228506
[TBL] [Abstract][Full Text] [Related]
23. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
24. Could KL-6 levels in COVID-19 help to predict lung disease?
Frix AN; Schoneveld L; Ladang A; Henket M; Duysinx B; Vaillant F; Misset B; Moutschen M; Louis R; Cavalier E; Guiot J
Respir Res; 2020 Nov; 21(1):309. PubMed ID: 33234132
[TBL] [Abstract][Full Text] [Related]
25. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.
Ohshimo S; Yokoyama A; Hattori N; Ishikawa N; Hirasawa Y; Kohno N
Biochem Biophys Res Commun; 2005 Dec; 338(4):1845-52. PubMed ID: 16289035
[TBL] [Abstract][Full Text] [Related]
26. MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis.
Bonella F; Long X; Ohshimo S; Horimasu Y; Griese M; Guzman J; Kohno N; Costabel U
Orphanet J Rare Dis; 2016 Apr; 11():48. PubMed ID: 27108412
[TBL] [Abstract][Full Text] [Related]
27. Serum KL-6 levels predict clinical outcomes and are associated with
Azekawa S; Chubachi S; Asakura T; Namkoong H; Sato Y; Edahiro R; Lee H; Tanaka H; Otake S; Nakagawara K; Fukushima T; Watase M; Sakurai K; Kusumoto T; Masaki K; Kamata H; Ishii M; Hasegawa N; Okada Y; Koike R; Kitagawa Y; Kimura A; Imoto S; Miyano S; Ogawa S; Kanai T; Fukunaga K;
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37230764
[TBL] [Abstract][Full Text] [Related]
28. Elevation of serum Krebs von den Lunge-6 levels in patients with tubulointerstitial nephritis and uveitis syndrome.
Kase S; Kitaichi N; Namba K; Miyazaki A; Yoshida K; Ishikura K; Ikeda M; Nakashima T; Ohno S
Am J Kidney Dis; 2006 Dec; 48(6):935-41. PubMed ID: 17162148
[TBL] [Abstract][Full Text] [Related]
29. Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis.
Mostafa AI; Salem AE; Ahmed HAM; Bayoumi AI; Halim RMA; Samie RMA
Tuberc Respir Dis (Seoul); 2021 Jul; 84(3):200-208. PubMed ID: 33840176
[TBL] [Abstract][Full Text] [Related]
30. CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases.
Kruit A; Gerritsen WB; Pot N; Grutters JC; van den Bosch JM; Ruven HJ
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):138-46. PubMed ID: 21319596
[TBL] [Abstract][Full Text] [Related]
31. [Interstitial lung disease and lung cancer].
Ishikawa N; Kohno N
Gan To Kagaku Ryoho; 2010 Jan; 37(1):6-9. PubMed ID: 20087026
[TBL] [Abstract][Full Text] [Related]
32. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of the glycosylated forms of MUC1 during lung development.
Sakurai J; Hattori N; Nakajima M; Moriya T; Suzuki T; Yokoyama A; Kohno N
Eur J Histochem; 2007; 51(2):95-102. PubMed ID: 17664159
[TBL] [Abstract][Full Text] [Related]
34. Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents.
Takahashi K; Nakamura H; Takenouchi K; Iizawa N; Koiwa M; Sato A; Mochizuki Y; Watanabe H; Takai S
J Nippon Med Sch; 2014; 81(6):364-71. PubMed ID: 25744479
[TBL] [Abstract][Full Text] [Related]
35. Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities.
Wakamoto H; Sano N; Yano Y; Sakai S; Kikuchi T; Fukuda M; Morimoto T; Ishii E
J Pediatr; 2015 Nov; 167(5):1136-42. PubMed ID: 26382626
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.
Fujiwara Y; Kiura K; Toyooka S; Hotta K; Tabata M; Takigawa N; Soh J; Tanimoto Y; Kanehiro A; Kato K; Date H; Tanimoto M
Lung Cancer; 2008 Jan; 59(1):81-7. PubMed ID: 17765355
[TBL] [Abstract][Full Text] [Related]
37. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of CA15-3, KL-6 and BCA225 are positively correlated with each other in the general population.
Ri G; Ohno S; Yamamoto T; Ito E; Furutani M; Furutani Y; Umeda Y; Tsukahara T; Hagita N; Matsuoka R
Anticancer Res; 2009 Oct; 29(10):4239-42. PubMed ID: 19846980
[TBL] [Abstract][Full Text] [Related]
39. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
[TBL] [Abstract][Full Text] [Related]
40. Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor-α therapy.
Higashi Y; Tada K; Shimokawa M; Kawai K; Kanekura T
Clin Exp Dermatol; 2016 Jan; 41(1):88-90. PubMed ID: 25557847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
